Medication info
Rodianty Tablet 40/5 mg (Telmisartan, Esamlodipine Nicotinic Acid Salt)

Rodianty Tablet 40/5 mg (Telmisartan, Esamlodipine Nicotinic Acid Salt)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletS-Amlodipine Nicotinate›6.506mg / 1 tablet
Manufacturer / importer
Hallym Pharmaceutical Co., Ltd.
Appearance
Light blue and white biconvex oval tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202104294 · Approved 2021.05.31 · Insurance code 645306570

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended to take it at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (S-amlodipine (amlodipine) or telmisartan). However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/2.5mg: For patients whose blood pressure is not adequately controlled with 2.5mg of S-amlodipine (5mg of amlodipine) or 40mg of telmisartan. - 80/2.5mg: For patients whose blood pressure is not adequately controlled with 2.5mg of S-amlodipine (5mg of amlodipine) or this medicine 40/2.5mg. - 40/5mg: For patients whose blood pressure is not adequately controlled with 5mg of S-amlodipine (10mg of amlodipine). - 80/5mg: For patients whose blood pressure is not adequately controlled with 5mg of S-amlodipine (10mg of amlodipine) or this medicine 40/5mg. Patients taking telmisartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience (only for this medicine 40/2.5mg and 80/5mg). ◦ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual dosage regimen of S-amlodipine (amlodipine) is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Administration with caution in the following patients’). In elderly patients aged 75 years or older, clearance of S-amlodipine (amlodipine) is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Child dose
The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Hallym Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This drug is used to effectively lower blood pressure in patients with essential hypertension where blood pressure is not sufficiently controlled with monotherapy of either Esamlodipine (Amlodipine) or Telmisartan alone. These drugs work by dilating blood vessels, facilitating smooth blood flow, and help in stable management of blood pressure. This reduces the burden on the heart and kidneys and contributes to the prevention of complications related to hypertension. Therefore, this medication is used as an effective treatment option for essential hypertension that is difficult to manage with monotherapy.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended to take it at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (S-amlodipine (amlodipine) or telmisartan). However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/2.5mg: For patients whose blood pressure is not adequately controlled with 2.5mg of S-amlodipine (5mg of amlodipine) or 40mg of telmisartan. - 80/2.5mg: For patients whose blood pressure is not adequately controlled with 2.5mg of S-amlodipine (5mg of amlodipine) or this medicine 40/2.5mg. - 40/5mg: For patients whose blood pressure is not adequately controlled with 5mg of S-amlodipine (10mg of amlodipine). - 80/5mg: For patients whose blood pressure is not adequately controlled with 5mg of S-amlodipine (10mg of amlodipine) or this medicine 40/5mg. Patients taking telmisartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience (only for this medicine 40/2.5mg and 80/5mg). ◦ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual dosage regimen of S-amlodipine (amlodipine) is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Administration with caution in the following patients’). In elderly patients aged 75 years or older, clearance of S-amlodipine (amlodipine) is reduced; therefore, start treatment at a low dose and increase the dose gradually.

Child dose

The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Precautions

This medicine can pose serious risks to the fetus, particularly during the second and third trimesters of pregnancy; therefore, women who are pregnant or may become pregnant should not take this medication. This medicine should not be used in patients with certain conditions, such as severe liver dysfunction, severe hypotension, or heart-related problems. Patients with impaired liver or kidney function, gastrointestinal diseases, and the elderly need to be particularly cautious when using this medication. Side effects such as dizziness or edema may occur with this drug, and in rare cases, severe adverse reactions may happen; thus, if any unusual symptoms occur, one should consult a physician immediately. This medication may interact with other drugs; therefore, patients should inform their healthcare provider of any other medications they are taking, particularly when using antihypertensive agents, diuretics, and anticoagulants. Pregnant or breastfeeding women should not take this medication, and women planning to become pregnant should be treated with alternative safer medications. Safety and efficacy in patients under 18 years old have not been adequately established, and usage in this age group is not recommended. In case of overdose, severe hypotension, dizziness, and heart abnormalities may occur, so it is crucial to adhere to prescribed dosages and seek medical help immediately if an overdose is suspected. This medication should be kept out of reach of children, and transferring it to another container could cause degradation in quality or accidents, so caution is advised.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 111 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyperglycemia
  • depression
  • insomnia
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory abnormality
  • sensory loss
  • taste disturbance
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • double vision
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gum hypertrophy
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • liver impairment
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • micturition disorder
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • weakness
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • intestinal vascular edema
  • interstitial lung disease
  • interstitial pneumonia
  • eosinophilic pneumonia
  • hepatocellular carcinoma
  • cerebral infarction
  • congestive heart failure
  • musculoskeletal pain
  • neck pain
  • nasopharyngitis
  • upper abdominal discomfort
  • upper abdominal pain
  • positional dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture; therefore, it should be kept in a tightly closed container. It is advisable to maintain the storage temperature between 1 and 30 degrees Celsius at room temperature. This will help preserve the efficacy of the drug and prevent deterioration.

Appearance and packaging

Appearance

Light blue and white biconvex oval tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.